A new medical test developed by Renatek Corporation is now available in Chiba Prefecture’s Shiraishi City. The “Metal Balance Test” uses just 6 milliliters of blood to assess the risk of cancer and mild cognitive impairment (MCI). The test is being offered at Chigusa Clinic, starting from October.
The test analyzes metal levels in the blood, which are linked to early signs of disease. It aims to provide early detection and help patients take preventive action. The clinic has begun accepting reservations for the test, marking a significant step in personalized healthcare.
The technology behind the test is based on advanced biochemical analysis. It is designed to be quick and non-invasive, making it accessible to a broader population. Patients can now get a comprehensive health assessment with minimal discomfort.
Renatek Corporation has emphasized the importance of early diagnosis in improving health outcomes. The test is part of a growing trend in preventive medicine, focusing on detecting risks before symptoms appear.
